JPX · 2784.T
Alfresa Holdings Corporation
¥2,469+¥29 (+1.19%)
Alfresa Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 8.06% below the high.
Loading market information…
JPX · 7459.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
MediPal Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.23% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
MediPal Holdings Corporation’s forward annual dividend is ¥88 per share, paid semi-annual. The forward yield is 2.56% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
MediPal Holdings Corporation’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of ¥70. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow MediPal Holdings Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:34 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2025 | May 13, 2025 | ¥20+14.54% vs estimate | ¥864.16B+0.76% vs estimate |
|---|
| Q3 2025 | Feb 10, 2025 | ¥70+85.23% vs estimate | ¥982.5B+2.45% vs estimate |
|---|
| Q2 2025 | Nov 1, 2024 | ¥61+13.94% vs estimate | ¥915.36B+0.3% vs estimate |
|---|
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥2,469+¥29 (+1.19%)
Alfresa Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 8.06% below the high.
¥2,994+¥99 (+3.4%)
Suzuken Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 10.2% below the high.
¥4,004+¥54 (+1.37%)
Toho Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.41% below the high.
¥2,576+¥27 (+1.06%)
AS ONE Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.75% below the high.
¥1,545+¥36 (+2.39%)
Vital KSK Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.54% below the high.
¥1,217-¥16 (-1.3%)
WIN-Partners Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.3% below the high.
¥1,920+¥9 (+0.47%)
OLBA HEALTHCARE HOLDINGS, Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.21% below the high.
¥737+¥6 (+0.82%)
Medius Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.63% below the high.
